Literature DB >> 19109170

Role of TNF-alpha produced by nonantigen-specific cells in a fulminant hepatitis mouse model.

Hiroyasu Ito1, Kazuki Ando, Tetsuya Ishikawa, Kuniaki Saito, Masao Takemura, Michio Imawari, Hisataka Moriwaki, Mitsuru Seishima.   

Abstract

In previous studies, the mechanisms of acute liver injury and virus exclusion have been examined using a model wherein HBsAg-specific CTL are injected into HBsAg transgenic (Tg) mice. The importance of the role of TNF-alpha in virus exclusion was shown, but its role in liver injury was unclear. We crossed the TNF-alpha knockout mouse and HBsAg-Tg mouse to establish the HBsAg-Tg/TNF-alpha KO mouse, and examined the influence of TNF-alpha on liver injury. The severity of liver damage, as determined by serum alanine aminotransferase activity, was approximately 100 times greater in HBsAg-Tg/TNF-alpha(+/+) than in HBsAg-Tg/TNF-alpha(-/-) mice after i.v. administration of 5 x 10(6) CTLs. This liver damage reached the peak of its severity within 24-48 h, and was restored 7 days later. Histopathological examination showed hepatocellular necrosis and inflammatory cell infiltrate 24 h after the CTL injection in HBsAg-Tg/TNF-alpha(+/+) mice but not in HBsAg-Tg/TNF-alpha(-/-) mice. The liver damage was fatal for all HBsAg-Tg/TNF-alpha(+/+) mice that received 1.5 x 10(7) CTLs. In contrast, 1.5 x 10(7) CTLs could not kill the HBsAg-Tg/TNF-alpha(-/-) mice. The TNF-alpha production level was enhanced after the CTL injection in not only intrahepatic macrophages but also other types of mononuclear cells from non-HBsAg-Tg/TNF-alpha(+/+) mice. An adoptive transfer examination revealed that severe liver damage occurred in HBsAg-Tg/TNF-alpha(-/-) mice that had received mononuclear cells from TNF-alpha(+/+) mice. In conclusion, the present study provides evidence that TNF-alpha produced by intrahepatic non-Ag-specific inflammatory cells is critical in the development of lethal necroinflammatory liver disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19109170     DOI: 10.4049/jimmunol.182.1.391

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Serum cytokine levels in patients with chronic hepatitis B according to lamivudine therapy.

Authors:  Younhee Park; Yongjung Park; Kwang-Hyub Han; Hyon-Suk Kim
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

2.  Deficiency of NALP3 Signaling Impairs Liver Regeneration After Partial Hepatectomy.

Authors:  Tatsuya Ando; Hiroyasu Ito; Ayumu Kanbe; Akira Hara; Mitsuru Seishima
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

3.  Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model.

Authors:  Hiroyasu Ito; Tatsuya Ando; Yuko Arioka; Kuniaki Saito; Mitsuru Seishima
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

4.  Induction of hepatitis B virus surface antigen-specific cytotoxic T lymphocytes can be up-regulated by the inhibition of indoleamine 2, 3-dioxygenase activity.

Authors:  Hiroyasu Ito; Tatsuya Ando; Kazuki Ando; Tetsuya Ishikawa; Kuniaki Saito; Hisataka Moriwaki; Mitsuru Seishima
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

Review 5.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

6.  Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen.

Authors:  Ian Baudi; Masanori Isogawa; Federica Moalli; Masaya Onishi; Keigo Kawashima; Yuji Ishida; Chise Tateno; Yusuke Sato; Hideyoshi Harashima; Hiroyasu Ito; Tetsuya Ishikawa; Takaji Wakita; Matteo Iannacone; Yasuhito Tanaka
Journal:  PLoS Pathog       Date:  2021-05-12       Impact factor: 6.823

7.  Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications.

Authors:  Anne Chastre; Mireille Bélanger; Elizabeth Beauchesne; Bich N Nguyen; Paul Desjardins; Roger F Butterworth
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

8.  High susceptibility to lipopolysaccharide-induced lethal shock in encephalomyocarditis virus-infected mice.

Authors:  Hirofumi Ohtaki; Hiroyasu Ito; Masato Hoshi; Yosuke Osawa; Manabu Takamatsu; Akira Hara; Tetsuya Ishikawa; Hisataka Moriwaki; Kuniaki Saito; Mitsuru Seishima
Journal:  Sci Rep       Date:  2012-04-16       Impact factor: 4.379

9.  Fulminant liver failure model with hepatic encephalopathy in the mouse.

Authors:  Tomohide Hori; Feng Chen; Ann-Marie T Baine; Lindsay B Gardner; Justin H Nguyen
Journal:  Ann Gastroenterol       Date:  2011

10.  Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model.

Authors:  Hiroyasu Ito; Tatsuya Ando; Mitsuru Seishima
Journal:  Oncotarget       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.